The Evolving Role of NGS and Germline Sequencing in Patients with Advanced and Metastatic Cancer

home / news-network / the-evolving-role-of-ngs-and-germline-sequencing-in-patients-with-advanced-and-metastatic-cancer

Experts discuss recent data on next generation sequencing and germline testing in patients with advanced and metastatic cancer.

Defining Germline Sequencing and Incidental Germline Findings

EP. 1: Defining Germline Sequencing and Incidental Germline Findings

July 22nd 2021

Mark Robson, MD, and a panel of experts discuss key terminology and definitions related to tumor and germline sequencing.

Tumor-Normal Matched Sequencing and Platforms Utilized for Tumor Profiling

EP. 2: Tumor-Normal Matched Sequencing and Platforms Utilized for Tumor Profiling

July 22nd 2021

Mark Robson, MD, reviews data from a recent abstract on incidental germline findings detected by tumor-normal matched sequencing and the panelists share which platforms they utilize for tumor profiling.

Experience with Interpreting Somatic Reports

EP. 3: Experience with Interpreting Somatic Reports

July 29th 2021

A panel of experts share their experiences with interpreting information on somatic reports and provide recommendations for verifying results.

Identification of Patients for Germline Testing

EP. 4: Identification of Patients for Germline Testing

July 29th 2021

The panel of experts provide insight on how they identify patients for germline testing.

Role of ctDNA in Germline Testing

EP. 5: Role of ctDNA in Germline Testing

August 5th 2021

Mark Robson, MD; John Henson, MD; Ashley Ross, MD, PhD; and Dana Farengo Clark, MS, LCGC, discuss the evolving role of circulating tumor DNA (ctDNA) in germline testing.

Operational Processes and Challenges

EP. 6: Operational Processes and Challenges

August 5th 2021

Mark Robson, MD; John Henson, MD; Ashley Ross, MD, PhD; and Dana Farengo Clark, MS, LCGC, discuss operational processes and techniques for counseling patients about germline testing.